Similar to the treatment of stroke mice with As IV, knocking out IL-17 promoted the neurogenesis and neuronal plasticity in the ipsilateral hippocampus and the proliferation of NSCs in vitro. The gene discussed is IL17A; the disease is stroke disorder.